Charts suggest the S&P 500 is at a make-or-break moment, Jim Cramer says

Charts suggest the S&P 500 is at a make-or-break moment, Jim Cramer says


CNBC’s Jim Cramer on Wednesday said that the benchmark S&P 500 is at a crossroads, poised to either tumble further or roar higher.

“The charts, as interpreted by Jessica Inskip, suggest that we’re all at a very important moment where the S&P 500 found an equilibrium between the floor of support and a ceiling of resistance. At this point, something has to give,” he said.

Stocks tumbled on Wednesday after fresh December retail sales data renewed fears of a recession. Investors also took profits on gains from earlier this month, spurred by soft economic data that suggested the Federal Reserve is winning its fight against inflation.

The S&P 500 fell to its lowest level in about a month, while the Nasdaq broke a seven-day streak of gains.

To explain the analysis from Inskip, who is the director of product and education at OptionsPlay, Cramer examined the daily chart of the S&P 500 dating back to November 2021.

The chart shows that earnings season is often a time of volatility marked by strong rallies and declines. It also shows that the S&P 500 has been on a downtrend for over a year, with the downtrend line acting as a ceiling of resistance for the market since the Federal Reserve began its battle against inflation in November 2021, according to Cramer.

Inskip notes that the ceiling has never been breached even after powerful rallies from the last two earnings cycles, he added.

But while the past two earnings seasons started with the index at levels close to the low end of its trading end, the current fourth-quarter earnings season saw the S&P 500 start right below the ceiling, Cramer said.

“Good [earnings] numbers could give us more upside than we’ve seen from the last few quarters, but bad ones might mean the S&P heads right back down to the low end of the range,” he said.

For more analysis, watch Cramer’s full explanation below.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Business

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg | Getty Images Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots. The FDA approved the pill, Icotyde, to treat […]

Read More
Macy’s store revamp shows progress, but company expects sales to fall this year
Business

Macy’s store revamp shows progress, but company expects sales to fall this year

Macy’s on Wednesday beat Wall Street’s quarterly sales and profit expectations as its namesake brand showed signs of progress, yet still gave a cautious outlook for the year ahead. For the fiscal year, the company – which includes its namesake chain, higher-end department store Bloomingdale’s and beauty retailer Bluemercury – said it expects sales of […]

Read More
Disney embarks on new chapter as Josh D’Amaro takes over as CEO
Business

Disney embarks on new chapter as Josh D’Amaro takes over as CEO

Larissa Manoela and Josh D’Amaro, Chairperson of Walt Disney Parks and Resorts, wave to the audience after Panel Disney Experiences during Day 2 of the D23 Brazil: A Disney Experience at Transamerica Expo Center on November 09, 2024 in Sao Paulo, Brazil. Ricardo Moreira | Getty Images Disney is turning the page on a new […]

Read More